Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8528 |
High Similarity |
NPD7473 |
Discontinued |
0.8457 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8301 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8228 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.815 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD37 |
Approved |
0.8065 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7949 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7911 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7852 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7824 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7811 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7811 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7785 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7657 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7657 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7654 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.747 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.747 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7467 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7427 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7325 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7296 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7285 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7261 |
Intermediate Similarity |
NPD943 |
Approved |
0.725 |
Intermediate Similarity |
NPD5406 |
Approved |
0.725 |
Intermediate Similarity |
NPD5408 |
Approved |
0.725 |
Intermediate Similarity |
NPD5405 |
Approved |
0.725 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7249 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD5242 |
Approved |
0.724 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD919 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7197 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD5736 |
Approved |
0.716 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7133 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD7236 |
Approved |
0.709 |
Intermediate Similarity |
NPD6779 |
Approved |
0.709 |
Intermediate Similarity |
NPD6780 |
Approved |
0.709 |
Intermediate Similarity |
NPD6782 |
Approved |
0.709 |
Intermediate Similarity |
NPD6781 |
Approved |
0.709 |
Intermediate Similarity |
NPD6777 |
Approved |
0.709 |
Intermediate Similarity |
NPD6778 |
Approved |
0.709 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7086 |
Intermediate Similarity |
NPD17 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7081 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7056 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7026 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7025 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7022 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD9268 |
Approved |
0.702 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7006
|
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |